The antifungal antibiotic aureobasidin A (AbA) is a cyclic depsipeptide composed of eight amino acids and a hydroxy acid. NewAb analogs were produced by feeding various amino acids to Aureobasidiumpullulans R106 c-712 in a chemically-defined mediumcontaining glucose and ammoniumsulfate. The constituent amino acids of AbAat positions 3 ( 
and L-norvaline, resulting in the production of eight new Ab analogs. This is the first paper to describe amino acid replacements at positions 3, 5 and 8. L-[l-13C]-Valine exogenously added was incorporated into the three valine-related moieties of AbAat positions 2, 7 (both iV-methyl-L-valine) and 9 (/?-hydroxy-Af-methyl-L-valine), but these moieties were never replaced by exogenous amino acid analogs. The comparative antifungal activities of AbAand the eight new Ab analogs were determined.
Aureobasidins (Abs) are a group of potent antifungal antibiotics produced by the black yeast Aureobasidium pullulans R106.1"5) AbA ( Fig.  1) , the major Ab, has a moderate spectrum of antifungal activity including Candida albicans in vitro.2) AbAwas orally effective in a murine infection model of candidiasis and showed very low toxicity.2) Consequently, AbA is a promising agent for use against systemic fungal infections. In addition to
AbA,we have isolated over 20 closely related congeners from the fermentation broth.1'3~5) Abs are cyclic JULY 1996 depsipeptides composed of a hydroxy acid and eight amino acids, three or four of which are TV-methylated.
Among the known Abs produced by A. pullulans R106, variations in the hydroxy or amino acids have been observed in moieties 1, 4, 6, 7 and 9, while variations in the rest (moieties 2, 3, 5 and 8) have not been previously described. 1'3^5) Studies of the structure-activity relationships of these Abs revealed that the amino acid at position 9 should be^hydroxy-JV-methyl-L-valine (jSHOMeVal) for potent antifungal activity.6) Manynew analogs have 
Materials and Methods Strain
A high AbA producer, strain c-712 derived from the original strain A. pullulans R106 (FERM BP-1938), was used in this study. The strain was obtained from the producing organism by repeated single colony isolation.
The original strain was cultured in 500-ml Erlenmeyer flasks each containing 100ml of GNmedium(glucose 2%, ammonium sulfate 0.5%, KH2PO4 0.15%, MgSO4 7H2O 0.05%, CaCl2-2H2O 0.01%, NaCl 0.1%, FeCl3-6H2O 0.5 /ig/ml and ZnSO4-7H2O 0.5 /jg/ml) for 4 days with shaking. Then the flasks were supplemented with 10ml each of 10x GN medium and 10% polypeptone four times at an interval of 4 days and cultured totally for 20 days. From each culture broth at days-12, -16 and -20 containing 260, 457 and 600/ig/ml of AbA, respectively, 80~100 strains were isolated by conventional single colony isolation. Each isolate was cultured in 7ml of GNmediumin a test tube for 4 days, supplemented once with 0.7ml each of IOxGNmedium and 10% polypeptone. After shaking for a further 4 days, the amount ofAbAin the culture was measured by HPLC.^The best isolate was cultivated in 500-ml Erlenmeyer flasks and supplemented twice with nutrients as described above for the next round of colony isolation. From day-8 and -12 culture broths containing 320 and 440/xg/ml of AbA, respectively, about 200 strains were isolated. Each isolate was cultured in a test tube as described above and the amount of AbAproduced was determined by HPLC.Strain c-712 was obtained as one of the best isolates. AbA productivities of strain c-712
and the original strain were 300~400 and 100~150 jUg/ml, respectively, after 10 x GN medium and polypeptone were supplemented once. If polypeptone was omitted, the AbA productivities of strain c-712 and the original strain dropped to 90~120 and 30~60jUg/ml, respectively.
Search for NewAb Analogs by Precursor Directed
Biosynthesis A loopful of cells from a slant culture of strain c-712 on potato dextrose agar medium(Nissui Pharmaceuticals, Japan) was inoculated into a tube containing 7ml ofYNBGmedium (0.67% Difco yeast nitrogen base and 2% glucose) and shaken for 2 days at 25°C. The generated 677 seed culture (0. 1 ml) was transferred to a tube containing 7 ml ofGNmediumand shaken for 4 days. To the culture, 0.7ml of 10xGNmediumand 8mg of an amino or hydroxy acid listed below (Nakalai Tesque Inc., Japan) were added. As the control fermentation, only 0.7ml of 10 x GN medium was added to a tube. The tubes were shaken for a further 4 days in duplicate. The culture broth was thoroughly mixed with an equal volume of ethanol and centrifuged. The supernatant was analyzed by reversed phase HPLC [column: Capcell Pak C18 (Shiseido Co., Ltd., Japan), 6mmi.d. x 250mm; column temperature: 50°C; mobile phase: acetonitrile-water (7 : 3), 1.0ml/minute; detection: UV 220nm].
The additives were (i) hydroxy acids for moiety 1 including DL-2-hydroxy-3-methylpentanoic acid (dlHmp), DL-2-hydroxyisovaleric acid (DL-Hiv), DL-2-hydroxybutyric acid, DL-2-hydroxyisobutyric acid, dl-2-hydroxyvaleric acid and DL-2-hydroxy-4-methylpentanoic acid; (ii) valine-related amino acids for moieties 2, 
Preparation of NewAb Analogs
One ml of the seed culture was transferred to 20~70 500-ml Erlenmeyer flasks containing 100ml of GN medium, which were shaken for 4 days at 25°C. To each flask, 10ml of IOxGN medium and 50~500mg of a precursor amino or hydroxy acid were added. After shaking for 4 days, each flask was again supplemented with 10ml of 10-XGN medium and 50~500mg of the additive, and shaken for a further 4 days. The culture broth (2~7 liters) was collected and centrifuged. Incorporation of 13C-labeled Val to AbA One ml of the seed culture was transferred into a 500-ml flask containing 100 ml ofGN medium, which was shaken for 4 days at 25°C. Thereafter, 10ml each of 10xGN mediumand 10%polypeptone were added to the culture. The flask was shaken for 2 days, then supplemented with lOOmg of [l-13C]Val (99atom %, Nippon Sanso Corp., Japan) and incubated for a further 2 days. The culture broth was centrifuged and the mycelial cake obtained was extracted with 10ml of methanol. The extract was concentrated to dryness under reduced pressure and the residue was dissolved in methanol (500 /^1). The solution was applied to a preparative HPLCcolumn as described above, to yield lOmg of Results and Discussion Incorporation of 13C-Val into AbA Fig. 2 One ml of the seed culture was inoculated to 100ml of GN medium in a 500-ml Erlenmeyer flask. After 4 days shaking, the culture (8ml) was transferred to test tubes containing IO x GNmedium (0.8ml) and additives (each 8mg), and incubated for a further 4 days. The amount of AbA produced in the culture broth was determined by HPLC.^Experiments were carried out in triplicate.
obtain new Abs, we added 0.1% each of various commercially available amino acids or hydroxy acids to GN mediumas mimics (see Materials and Methods section). Although AbAwas the main product in all the additivefed fermentations, we succeeded in derivation of new Ab analogs when Nle, Nva, alle, <9FPhe, raFPhe, 4Hyp, SPro, and Met were fed as precursors (Table 2 ). Nle and <9FPhe easily replaced alle6 and Phe3 plus MePhe4, respectively. The structures of new Ab analogs were deduced by FAB-MSand amino acid analysis ( Table 3 Abbreviations:
Nle, L-norleuine; Nva, L-norvaline. * The a-value is defined as the relative retention time K^r,i~to)/(tR>2-10)] x 10, where tRjl and tR 2 mean the retention times ofa new Ab and AbA, respectively, and t0 is the dead retention time. As reference compound, AbA is taken (a=10.0). ** The production of new Abs and AbA was determined by comparing the HPLC with that of a AbA standard solution.
Thus, difficulty in hydroxylation of the valine analogs may be the reason that we did not discover such Ab analogs.
Aminoacids at positions 3 and 4 are probably derived from Phe, and thus aromatic amino acids, Tyr, oFPhe and raFPhe were incorporated (Table 2) (Table 2) . Interestingly, Met, which differs from other aliphatic amino acids of moiety 6 and was used as the TV-methyl donor of the four TV-methylated moieties of AbA(data not shown), was incorporated into this position. Leu8, which is analogous to alle at position 6 ofAbA, was substituted by exogenous Nva but alle6 was not. decreased that of AbA to 58%, whereas normally AbA and AbBare 89 and 3%of the total, respectively. In contrast, DL-2-hydroxybutyric acid, DL-2-hydroxyisobutyric acid, DL-2-hydroxyvaleric acid and DL-2-hydroxy-4-methylpentanoic acid were not incorporated. The hydroxy acids were inhibitory to growth of the producing organism and the production of Abs: specifically JULY 1996 DL-2-hydroxy-4-methylpentanoic acid showed strong growth inhibition and 70% inhibition of AbAproduction. However, the result shown in Table 1 The anti-cryptococcal activity was more easily reduced than the anti-candidal activity by a subtle change in constituent amino acids.1'40 [alle8]-AbA was more active against Candida sp. than AbAand was as potent as AbA against C. neoformans. Replacement of Pro5 by
